Ghent University Academic Bibliography

Advanced

The effect of long-term oral L-carnitine administration on insulin sensitivity, glucose disposal, plasma concentrations of leptin and acylcarnitines, and urinary acylcarnitine excretion in warmblood horses

LC Kranenburg, CM Westermann, MGM de Sain-van der Velden, E de Graaf-Roelfsema, J Buyse, Geert Janssens UGent, J van den Broek and JH van der Kolk (2014) VETERINARY QUARTERLY. 34(2). p.85-91
abstract
Background: Insulin resistance in horses is an emerging field of interest as it is thought to be a contributing factor in the pathogenesis of many equine conditions. Objectives: The objectives of the present study were to determine the effects of long-term oral administration of L-carnitine on insulin sensitivity, glucose disposal, plasma leptin concentrations and acylcarnitine spectrum both in plasma and urine. Animals and methods: Six 3-year-old healthy warmblood geldings were used. In a double blind 2 x 2 Latin square design at a dosage of 100 mg/kg body weight (BW)/day for 28 days the effects of oral supplementation of L-carnitine (as fumarate) were assessed. Glucose disposal and insulin sensitivity were measured by means of the euglycemichyperinsulinemic clamp technique. Radioimmunoassays were used to determine plasma leptin and insulin concentrations. Electrospray tandem mass spectrometry was used to assess acylcarnitines both in plasma and urine. Statistical analysis was performed using a linear mixed-effects model and P values <0.05 were considered significant. Results: Long-term L-carnitine administration did not affect insulin sensitivity. Plasma leptin and free carnitine concentrations in plasma and urine increased significantly (P = 0.047 and 0.000, respectively) following L-carnitine administration as well as short-chain acylcarnitines in plasma and urinary excretion of short-and medium-chain acylcarnitines. Conclusion and clinical relevance: Given the effects of oral administration of L-carnitine further clinical study is necessary in order to assess the potential beneficial effects in equine patients suffering from metabolic myopathies such as acquired multiple acyl-CoA dehydrogenase deficiency. Impact for human medicine: The current study supports the treatment rationale of short-chain acyl-CoA dehydrogenase deficiency in humans with L-carnitine at an oral dosage of 100 mg/kg BW/day.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
insulin sensitivity, acylcarnitine, glucose, L-carnitine, horse, equine, leptin, COA DEHYDROGENASE-DEFICIENCY, ATYPICAL MYOPATHY, CLINICAL-FEATURES, DIABETIC-PATIENTS, SUPPLEMENTATION, METABOLISM, RESISTANCE, EXERCISE, HISTORY, PONIES
journal title
VETERINARY QUARTERLY
Vet. Q.
volume
34
issue
2
pages
85 - 91
Web of Science type
Article
Web of Science id
000342291700005
JCR category
VETERINARY SCIENCES
JCR impact factor
0.719 (2014)
JCR rank
82/133 (2014)
JCR quartile
3 (2014)
ISSN
0165-2176
DOI
10.1080/01652176.2014.919745
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
7898502
handle
http://hdl.handle.net/1854/LU-7898502
date created
2016-06-28 12:21:39
date last changed
2016-12-19 15:40:29
@article{7898502,
  abstract     = {Background: Insulin resistance in horses is an emerging field of interest as it is thought to be a contributing factor in the pathogenesis of many equine conditions. 
Objectives: The objectives of the present study were to determine the effects of long-term oral administration of L-carnitine on insulin sensitivity, glucose disposal, plasma leptin concentrations and acylcarnitine spectrum both in plasma and urine. 
Animals and methods: Six 3-year-old healthy warmblood geldings were used. In a double blind 2 x 2 Latin square design at a dosage of 100 mg/kg body weight (BW)/day for 28 days the effects of oral supplementation of L-carnitine (as fumarate) were assessed. Glucose disposal and insulin sensitivity were measured by means of the euglycemichyperinsulinemic clamp technique. Radioimmunoassays were used to determine plasma leptin and insulin concentrations. Electrospray tandem mass spectrometry was used to assess acylcarnitines both in plasma and urine. Statistical analysis was performed using a linear mixed-effects model and P values {\textlangle}0.05 were considered significant. 
Results: Long-term L-carnitine administration did not affect insulin sensitivity. Plasma leptin and free carnitine concentrations in plasma and urine increased significantly (P = 0.047 and 0.000, respectively) following L-carnitine administration as well as short-chain acylcarnitines in plasma and urinary excretion of short-and medium-chain acylcarnitines. 
Conclusion and clinical relevance: Given the effects of oral administration of L-carnitine further clinical study is necessary in order to assess the potential beneficial effects in equine patients suffering from metabolic myopathies such as acquired multiple acyl-CoA dehydrogenase deficiency. 
Impact for human medicine: The current study supports the treatment rationale of short-chain acyl-CoA dehydrogenase deficiency in humans with L-carnitine at an oral dosage of 100 mg/kg BW/day.},
  author       = {Kranenburg, LC and Westermann, CM and de Sain-van der Velden, MGM and de Graaf-Roelfsema, E and Buyse, J and Janssens, Geert and van den Broek, J and van der Kolk, JH},
  issn         = {0165-2176},
  journal      = {VETERINARY QUARTERLY},
  keyword      = {insulin sensitivity,acylcarnitine,glucose,L-carnitine,horse,equine,leptin,COA DEHYDROGENASE-DEFICIENCY,ATYPICAL MYOPATHY,CLINICAL-FEATURES,DIABETIC-PATIENTS,SUPPLEMENTATION,METABOLISM,RESISTANCE,EXERCISE,HISTORY,PONIES},
  language     = {eng},
  number       = {2},
  pages        = {85--91},
  title        = {The effect of long-term oral L-carnitine administration on insulin sensitivity, glucose disposal, plasma concentrations of leptin and acylcarnitines, and urinary acylcarnitine excretion in warmblood horses},
  url          = {http://dx.doi.org/10.1080/01652176.2014.919745},
  volume       = {34},
  year         = {2014},
}

Chicago
Kranenburg, LC, CM Westermann, MGM de Sain-van der Velden, E de Graaf-Roelfsema, J Buyse, Geert Janssens, J van den Broek, and JH van der Kolk. 2014. “The Effect of Long-term Oral L-carnitine Administration on Insulin Sensitivity, Glucose Disposal, Plasma Concentrations of Leptin and Acylcarnitines, and Urinary Acylcarnitine Excretion in Warmblood Horses.” Veterinary Quarterly 34 (2): 85–91.
APA
Kranenburg, L., Westermann, C., de Sain-van der Velden, M., de Graaf-Roelfsema, E., Buyse, J., Janssens, G., van den Broek, J., et al. (2014). The effect of long-term oral L-carnitine administration on insulin sensitivity, glucose disposal, plasma concentrations of leptin and acylcarnitines, and urinary acylcarnitine excretion in warmblood horses. VETERINARY QUARTERLY, 34(2), 85–91.
Vancouver
1.
Kranenburg L, Westermann C, de Sain-van der Velden M, de Graaf-Roelfsema E, Buyse J, Janssens G, et al. The effect of long-term oral L-carnitine administration on insulin sensitivity, glucose disposal, plasma concentrations of leptin and acylcarnitines, and urinary acylcarnitine excretion in warmblood horses. VETERINARY QUARTERLY. 2014;34(2):85–91.
MLA
Kranenburg, LC, CM Westermann, MGM de Sain-van der Velden, et al. “The Effect of Long-term Oral L-carnitine Administration on Insulin Sensitivity, Glucose Disposal, Plasma Concentrations of Leptin and Acylcarnitines, and Urinary Acylcarnitine Excretion in Warmblood Horses.” VETERINARY QUARTERLY 34.2 (2014): 85–91. Print.